Beta Blockers in Contemporary Cardiology: Is It Better to Cast Them Out?
Open Access
- 1 January 2024
- journal article
- review article
- Published by XMLink in Korean Circulation Journal
- Vol. 54 (4) , 165-171
Abstract
Dar JA, et al. Korean Circ J. 2024 Apr;54(4):165-171. https://doi.org/10.4070/kcj.2023.0209Keywords
This publication has 41 references indexed in Scilit:
- Central Pressure More Strongly Relates to Vascular Disease and Outcome Than Does Brachial PressureHypertension, 2007
- Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical OutcomesCirculation, 2006
- Rate Control and Quality of Life in Patients With Permanent Atrial Fibrillation The Quality Of Life and Atrial Fibrillation (QOLAF) StudyCirculation Journal, 2006
- Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysisThe Lancet, 2005
- Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialThe Lancet, 2005
- Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenololJACC, 2005
- The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trialCurrent Controlled Trials in Cardiovascular Medicine, 2001
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.1999
- Effect of Verapamil and Procainamide on Atrial Fibrillation–Induced Electrical Remodeling in HumansCirculation, 1997